Improving Endocrine Therapy for Breast Cancer: It's Not That Simple

被引：25

作者：

Dees, E. Claire ^{[1
]}

Carey, Lisa A. ^{[1
]}

机构：

[1] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 02期

关键词：

AROMATASE INHIBITORS; EVEROLIMUS; TAMOXIFEN; TEMSIROLIMUS; FULVESTRANT; COMBINATION; RESISTANCE; LETROZOLE; TRIAL;

D O I：

10.1200/JCO.2012.46.2655

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：171 / 173

页数：3

共 25 条

[1] Cytochrome P450 3A polymorphisms and immunosuppressive drugs:: an update [J].

Anglicheau, Dany ;

Legendre, Christophe ;

Beaune, Philippe ;

Thervet, Eric .

PHARMACOGENOMICS, 2007, 8 (07) :835-849

[2] Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study [J].

Bachelot, Thomas ;

Bourgier, Celine ;

Cropet, Claire ;

Ray-Coquard, Isabelle ;

Ferrero, Jean-Marc ;

Freyer, Gilles ;

Abadie-Lacourtoisie, Sophie ;

Eymard, Jean-Christophe ;

Debled, Marc ;

Spaeth, Dominique ;

Legouffe, Eric ;

Allouache, Djelila ;

El Kouri, Claude ;

Pujade-Lauraine, Eric .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (22) :2718-2724

[3] Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer [J].

Baselga, Jose ;

Campone, Mario ;

Piccart, Martine ;

Burris, Howard A., III ;

Rugo, Hope S. ;

Sahmoud, Tarek ;

Noguchi, Shinzaburo ;

Gnant, Michael ;

Pritchard, Kathleen I. ;

Lebrun, Fabienne ;

Beck, J. Thaddeus ;

Ito, Yoshinori ;

Yardley, Denise ;

Deleu, Ines ;

Perez, Alejandra ;

Bachelot, Thomas ;

Vittori, Luc ;

Xu, Zhiying ;

Mukhopadhyay, Pabak ;

Lebwohl, David ;

Hortobagyi, Gabriel N. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (06) :520-529

[4] Phase II Randomized Study of Neoadjuvant Everolimus Plus Letrozole Compared With Placebo Plus Letrozole in Patients With Estrogen Receptor-Positive Breast Cancer [J].

Baselga, Jose ;

Semiglazov, Vladimir ;

van Dam, Peter ;

Manikhas, Alexey ;

Bellet, Meritxell ;

Mayordomo, Jose ;

Campone, Mario ;

Kubista, Ernst ;

Greil, Richard ;

Bianchi, Giulia ;

Steinseifer, Jutta ;

Molloy, Betty ;

Tokaji, Erika ;

Gardner, Humphrey ;

Phillips, Penny ;

Stumm, Michael ;

Lane, Heidi A. ;

Dixon, J. Michael ;

Jonat, Walter ;

Rugo, Hope S. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (16) :2630-2637

[5] FACT: An Open-Label Randomized Phase III Study of Fulvestrant and Anastrozole in Combination Compared With Anastrozole Alone As First-Line Therapy for Patients With Receptor-Positive Postmenopausal Breast Cancer [J].

Bergh, Jonas ;

Jonsson, Per-Ebbe ;

Lidbrink, Elisabet Kerstin ;

Trudeau, Maureen ;

Eiermann, Wolfgang ;

Brattstrom, Daniel ;

Lindemann, Justin P. O. ;

Wiklund, Fredrik ;

Henriksson, Roger .

JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (16) :1919-1925

[6]

Chulikavit M, 2010, 2010 GEN CANC S SAN

[7]

Clark AS, 2002, MOL CANCER THER, V1, P707

[8] Inhibition of mTOR activity restores tamoxifen response in breast cancer cells with aberrant Akt activity [J].

DeGraffenried, LA ;

Friedrichs, WE ;

Russell, DH ;

Donzis, EJ ;

Middleton, AK ;

Silva, JM ;

Roth, RA ;

Hidalgo, M .

CLINICAL CANCER RESEARCH, 2004, 10 (23) :8059-8067

[9] Lower-Dose vs High-Dose Oral Estradiol Therapy of Hormone Receptor-Positive, Aromatase Inhibitor-Resistant Advanced Breast Cancer A Phase 2 Randomized Study [J].

Ellis, Matthew J. ;

Gao, Feng ;

Dehdashti, Farrokh ;

Jeffe, Donna B. ;

Marcom, P. Kelly ;

Carey, Lisa A. ;

Dickler, Maura N. ;

Silverman, Paula ;

Fleming, Gini F. ;

Kommareddy, Aruna ;

Jamalabadi-Majidi, S. ;

Crowder, Robert ;

Siegel, Barry A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (07) :774-780

[10] Aromatase inhibitors: Combinations with fulvestrant or signal transduction inhibitors as a strategy to overcome endocrine resistance [J].

Johnston, SRD ;

Martin, LA ;

Head, J ;

Smith, I ;

Dowsett, M .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2005, 95 (1-5) :173-181

← 1 2 3 →